Strategic selective treatment in highly pre-treated HIV patients harbouring multiply resistant viruses

AIDS. 2002 Jan 25;16(2):298-9. doi: 10.1097/00002030-200201250-00024.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active
  • CD4 Lymphocyte Count
  • Drug Resistance, Multiple, Viral*
  • Female
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • HIV Infections / virology
  • HIV Protease Inhibitors / therapeutic use*
  • HIV-1 / drug effects*
  • HIV-1 / immunology
  • HIV-1 / physiology
  • Humans
  • Male
  • Prospective Studies
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Virus Replication / drug effects

Substances

  • Anti-HIV Agents
  • HIV Protease Inhibitors
  • Reverse Transcriptase Inhibitors